Coronavirus-induced autoimmunity

The pandemic of Coronavirus disease 2019 (COVID-19), caused by a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spotlighted the link between viral infection and autoimmunity. In this review, we focus on coronavirus-induced autoimmunity based on evidence from experimental anima...

Descripción completa

Detalles Bibliográficos
Autor principal: Salle, Valéry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005338/
https://www.ncbi.nlm.nih.gov/pubmed/33610741
http://dx.doi.org/10.1016/j.clim.2021.108694
_version_ 1783672106271113216
author Salle, Valéry
author_facet Salle, Valéry
author_sort Salle, Valéry
collection PubMed
description The pandemic of Coronavirus disease 2019 (COVID-19), caused by a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spotlighted the link between viral infection and autoimmunity. In this review, we focus on coronavirus-induced autoimmunity based on evidence from experimental animal models, SARS-CoV infection with in vitro studies of molecular mimicry and COVID-19 with several clinical reports of autoimmune manifestations of this disease. Further studies will be needed to better characterize the role of SARS-CoV-2 in the development of autoimmunity.
format Online
Article
Text
id pubmed-8005338
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-80053382021-03-29 Coronavirus-induced autoimmunity Salle, Valéry Clin Immunol Review Article The pandemic of Coronavirus disease 2019 (COVID-19), caused by a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spotlighted the link between viral infection and autoimmunity. In this review, we focus on coronavirus-induced autoimmunity based on evidence from experimental animal models, SARS-CoV infection with in vitro studies of molecular mimicry and COVID-19 with several clinical reports of autoimmune manifestations of this disease. Further studies will be needed to better characterize the role of SARS-CoV-2 in the development of autoimmunity. Elsevier Inc. 2021-05 2021-02-19 /pmc/articles/PMC8005338/ /pubmed/33610741 http://dx.doi.org/10.1016/j.clim.2021.108694 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review Article
Salle, Valéry
Coronavirus-induced autoimmunity
title Coronavirus-induced autoimmunity
title_full Coronavirus-induced autoimmunity
title_fullStr Coronavirus-induced autoimmunity
title_full_unstemmed Coronavirus-induced autoimmunity
title_short Coronavirus-induced autoimmunity
title_sort coronavirus-induced autoimmunity
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005338/
https://www.ncbi.nlm.nih.gov/pubmed/33610741
http://dx.doi.org/10.1016/j.clim.2021.108694
work_keys_str_mv AT sallevalery coronavirusinducedautoimmunity

Ejemplares similares